Jump in syphilis cases for second year in a row

Homosexual males account for the majority of cases

The number of cases of newly-developed syphilis recorded in Denmark jumped by more than 50 percent in 2014.

Last year there were 530 cases of the disease found in 523 patients compared to 352 cases in 2013, according to the health agency Statens Serums Institut (SSI).

The sexually-transmitted disease was all but absent from the country at the beginning of the century, but the number of reported cases climbed during the following decade and peaked in 2011. There was a fall in 2012, followed by further increases in 2013 and 2014.

More than 90 percent of the total instances last year were detected in men and 83 percent of them were homosexual.

SSI highlights, though, that the fact that 20 women were infected points to the syphilis also being spread among the heterosexual population.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.